Thermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $5.44, $0.19 better than the analyst estimate of $5.25. Revenue for the quarter came in at $11.01 billion versus the consensus estimate of $10.87 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.